TY - CHAP
T1 - Chemical-induced estrogenicity
AU - Safe, Stephen H.
AU - Khan, Shaheen
AU - Wu, Fei
AU - Li, Xiangrong
N1 - Funding Information:
Financial support for preparation of this chapter has been provided by the National Institutes of Health (R01-ES004917 and P30-ES09106) and the Texas Agricultural Experiment Station.
Publisher Copyright:
© 2007 Elsevier Ltd All rights reserved.
PY - 2007/3/14
Y1 - 2007/3/14
N2 - 17β-estradiol (E2) and the related steroidal hormones play an important role in multiple physiological processes. However, these hormones are risk factors for hormone-dependent diseases including breast and endometrial cancer. Inappropriate exposures (high or low) to estrogens can also lead to adverse health effects. The identification of estrogenic compounds in the environment, coupled with human exposures to these compounds, has generated public, regulatory, and scientific concern regarding their potential hormonal toxicity to humans and wildlife. This chapter focuses on chemical-induced estrogenicity and the potential toxicological impacts of these compounds. It also describes several different structural classes of synthetic estrogenic compounds, phytoestrogens, and estrogens/antiestrogens such as diethylstilbestrol and tamoxifen that are used as pharmaceutical agents. In addition, the mechanism of estrogen action and implications for risk assessment of these compounds are also discussed. These factors highlight the challenges faced by scientists and regulators in addressing the health risks and benefits of estrogenic compounds.
AB - 17β-estradiol (E2) and the related steroidal hormones play an important role in multiple physiological processes. However, these hormones are risk factors for hormone-dependent diseases including breast and endometrial cancer. Inappropriate exposures (high or low) to estrogens can also lead to adverse health effects. The identification of estrogenic compounds in the environment, coupled with human exposures to these compounds, has generated public, regulatory, and scientific concern regarding their potential hormonal toxicity to humans and wildlife. This chapter focuses on chemical-induced estrogenicity and the potential toxicological impacts of these compounds. It also describes several different structural classes of synthetic estrogenic compounds, phytoestrogens, and estrogens/antiestrogens such as diethylstilbestrol and tamoxifen that are used as pharmaceutical agents. In addition, the mechanism of estrogen action and implications for risk assessment of these compounds are also discussed. These factors highlight the challenges faced by scientists and regulators in addressing the health risks and benefits of estrogenic compounds.
UR - http://www.scopus.com/inward/record.url?scp=85135552497&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135552497&partnerID=8YFLogxK
U2 - 10.1016/B978-012370467-2/50162-0
DO - 10.1016/B978-012370467-2/50162-0
M3 - Chapter
AN - SCOPUS:85135552497
SN - 9780123704672
SP - 811
EP - 822
BT - Veterinary Toxicology
PB - Elsevier
ER -